IL118636A - Oral pharmaceutical compositions of S(+)-etodolac - Google Patents

Oral pharmaceutical compositions of S(+)-etodolac

Info

Publication number
IL118636A
IL118636A IL11863696A IL11863696A IL118636A IL 118636 A IL118636 A IL 118636A IL 11863696 A IL11863696 A IL 11863696A IL 11863696 A IL11863696 A IL 11863696A IL 118636 A IL118636 A IL 118636A
Authority
IL
Israel
Prior art keywords
etodolac
pharmaceutical compositions
oral pharmaceutical
oral
compositions
Prior art date
Application number
IL11863696A
Other languages
English (en)
Other versions
IL118636A0 (en
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of IL118636A0 publication Critical patent/IL118636A0/xx
Publication of IL118636A publication Critical patent/IL118636A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058—Chewing gums
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
IL11863696A 1995-06-13 1996-06-12 Oral pharmaceutical compositions of S(+)-etodolac IL118636A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17195P 1995-06-13 1995-06-13

Publications (2)

Publication Number Publication Date
IL118636A0 IL118636A0 (en) 1996-10-16
IL118636A true IL118636A (en) 2000-02-17

Family

ID=21690247

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11863696A IL118636A (en) 1995-06-13 1996-06-12 Oral pharmaceutical compositions of S(+)-etodolac

Country Status (26)

Country Link
US (1) US5958445A (xx)
EP (1) EP0748628A3 (xx)
JP (1) JPH093071A (xx)
KR (1) KR970000228A (xx)
CN (1) CN1152434A (xx)
AR (1) AR003435A1 (xx)
AU (1) AU711853B2 (xx)
BR (1) BR9602758A (xx)
CA (1) CA2178686A1 (xx)
CO (1) CO4700456A1 (xx)
CZ (1) CZ170296A3 (xx)
EA (1) EA000047B1 (xx)
EE (1) EE9600067A (xx)
HU (1) HUP9601635A3 (xx)
IL (1) IL118636A (xx)
IN (1) IN182040B (xx)
MA (1) MA23907A1 (xx)
NO (1) NO962491L (xx)
NZ (1) NZ286791A (xx)
PE (1) PE10898A1 (xx)
PL (1) PL314732A1 (xx)
SG (1) SG46737A1 (xx)
SK (1) SK74396A3 (xx)
SV (1) SV1996000051A (xx)
TR (1) TR199600499A2 (xx)
ZA (1) ZA964928B (xx)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2273409T3 (es) 1997-03-28 2007-05-01 Eisai Co., Ltd. Medicamento oral que previene el sabor desagradable y similar.
CN1227001C (zh) * 1999-09-10 2005-11-16 兰贝克赛实验室有限公司 依托度酸的缓释制剂
WO2001021178A2 (en) * 1999-09-22 2001-03-29 Akzo Nobel, N.V. Method of treating cognitive dysfunction syndrome in dogs and chewable tablet for dogs
KR100416242B1 (ko) * 1999-12-22 2004-01-31 주식회사 삼양사 약물전달체용 생분해성 블록 공중합체의 액체 조성물 및이의 제조방법
DK1260215T3 (da) * 2000-03-01 2009-11-09 Eisai R&D Man Co Ltd Hurtig disintegrerende tablet indeholdende polyvinylalkohol
US6514537B1 (en) 2000-06-02 2003-02-04 Cumberland Swan Holdings, Inc. Magnesium citrate solution
CN1638739A (zh) * 2000-08-18 2005-07-13 法玛西雅厄普约翰美国公司 治疗成瘾性障碍的化合物
EP1309315B1 (en) * 2000-08-18 2006-06-14 Pharmacia Corporation Rapidly disintegrating oral formulation of valdecoxib
HUP0400098A2 (hu) * 2001-02-27 2004-04-28 Ranbaxy Laboratories Limited Gyorsan kioldódó ciklooxigenáz-2 enzimgátló hatóanyagot tartalmazó tabletták és eljárás az előállításukra
KR20040058189A (ko) * 2001-09-26 2004-07-03 파마시아 코포레이션 관능상 허용가능한 경구내 붕해 조성물
US20040137052A1 (en) * 2001-12-25 2004-07-15 Yoshihiro Uchiyama Acid-containing preparations
US20040037869A1 (en) 2002-08-16 2004-02-26 Douglas Cleverly Non-animal product containing veterinary formulations
US20040151759A1 (en) * 2002-08-16 2004-08-05 Douglas Cleverly Non-animal product containing veterinary formulations
AR045142A1 (es) 2003-07-30 2005-10-19 Novartis Ag Composicion veterinaria masticable ductil de buen sabor
GB0320854D0 (en) 2003-09-05 2003-10-08 Arrow No 7 Ltd Buccal drug delivery
ES2372959T3 (es) 2004-01-29 2012-01-30 Medrx Co., Ltd. Analgésico anti-inflamatorio para uso externo.
US20080255104A1 (en) * 2004-05-04 2008-10-16 Equitech Corporation Nsaid Compositions
BRPI0602825A2 (pt) * 2006-06-23 2012-04-24 Rhodia Br Ltda formulação de pó efervescente auto-refrigerante para bebidas e uso de formulação em pó efervescente
US20090258823A1 (en) * 2006-12-08 2009-10-15 George Caroline L S Composition and methods for the prevention and treatment of gastrointestinal infections
PL2811998T3 (pl) 2012-02-06 2019-05-31 Merial Inc Pasożytobójcze doustne kompozycje weterynaryjne obejmujące ogólnoukładowo działające środki aktywne, sposoby oraz ich zastosowania
US20150057321A1 (en) 2012-04-04 2015-02-26 Intervet Inc. Soft chewable pharmaceutical products
WO2013169218A1 (en) * 2012-05-08 2013-11-14 Mahmut Bilgic Pharmaceutical compositions of s-etodolac

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2260148A (en) * 1939-06-19 1941-10-21 Frank H Fleer Corp Chewing gum material
GB971700A (en) * 1961-02-02 1964-09-30 Boots Pure Drug Co Ltd Anti-Inflammatory Agents
US3939178A (en) * 1971-06-01 1976-02-17 American Home Products Corporation Certain pyrano [3,4-b]indoles and thiopyrano[3,4-b]indoles
GB1548022A (en) * 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
CA1097233A (en) * 1977-07-20 1981-03-10 George K. E. Gregory Packages
US4265847A (en) * 1978-03-30 1981-05-05 Kirby Pharmaceuticals Ltd Tabletting process
US4520203A (en) * 1983-08-16 1985-05-28 American Home Products Corporation Resolution of (±)-1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indole-1-acetic acid using cinchonine
US4639368A (en) * 1984-08-23 1987-01-27 Farmacon Research Corporation Chewing gum containing a medicament and taste maskers
US4879108A (en) * 1985-12-20 1989-11-07 Warner-Lambert Company Confectionery delivery system for antipyretics
US4764378A (en) * 1986-02-10 1988-08-16 Zetachron, Inc. Buccal drug dosage form
ES2055685T3 (es) * 1986-11-14 1994-09-01 Puetter Medice Chem Pharm Procedimiento para la obtencion de un medicamento que contiene ibuprofen.
US4800087A (en) * 1986-11-24 1989-01-24 Mehta Atul M Taste-masked pharmaceutical compositions
US4835186A (en) * 1987-06-15 1989-05-30 American Home Products Corporation Spray dried ibuprofen
US4835187A (en) * 1987-06-15 1989-05-30 American Home Products Corporation Spray dried ibuprofen
US4788220A (en) * 1987-07-08 1988-11-29 American Home Products Corporation (Del.) Pediatric ibuprofen compositions
US4851444A (en) * 1987-07-10 1989-07-25 Analgesic Associates Onset-hastened/enhanced analgesia
IE60311B1 (en) * 1987-09-24 1994-06-29 American Home Prod Sustained release etodolac
US4861797A (en) * 1987-10-15 1989-08-29 Oratech Pharmaceutical Development Corporation Liquid ibuprofen compositions and methods of making them
US4851226A (en) * 1987-11-16 1989-07-25 Mcneil Consumer Products Company Chewable medicament tablet containing means for taste masking
US4835188A (en) * 1987-12-08 1989-05-30 American Home Products Corporation Spray dried ibuprofen
US4942039A (en) * 1989-05-09 1990-07-17 Miles Inc. Effervescent analgesic antacid composition having reduced sodium content
GB8909793D0 (en) * 1989-04-28 1989-06-14 Beecham Group Plc Pharmaceutical formulation
US5084278A (en) * 1989-06-02 1992-01-28 Nortec Development Associates, Inc. Taste-masked pharmaceutical compositions
US5190981A (en) * 1989-08-17 1993-03-02 Sepracor Inc. Formulation containing S(+) enantiomer of flurbiprofen or ketoprofen and method of use for oral administration for prevention and treatment of bone loss associated with periodontal disease
US5380535A (en) * 1991-05-28 1995-01-10 Geyer; Robert P. Chewable drug-delivery compositions and methods for preparing the same
WO1993017680A1 (en) * 1992-03-13 1993-09-16 Sepracor, Inc. Antipyretic and analgesic methods and compositions containing optically pure r-etodolac
GB9224021D0 (en) * 1992-11-16 1993-01-06 Boots Co Plc Effervescent compositions
US5458879A (en) * 1994-03-03 1995-10-17 The Procter & Gamble Company Oral vehicle compositions

Also Published As

Publication number Publication date
IL118636A0 (en) 1996-10-16
CA2178686A1 (en) 1996-12-14
EE9600067A (et) 1996-12-16
SG46737A1 (en) 1998-02-20
EP0748628A3 (en) 1997-04-23
BR9602758A (pt) 1998-04-22
TR199600499A2 (tr) 1996-12-21
ZA964928B (en) 1997-12-10
NO962491L (no) 1996-12-16
PL314732A1 (en) 1996-12-23
PE10898A1 (es) 1998-03-20
NO962491D0 (no) 1996-06-12
CZ170296A3 (en) 1997-04-16
AR003435A1 (es) 1998-08-05
MA23907A1 (fr) 1996-12-31
SK74396A3 (en) 1997-04-09
EP0748628A2 (en) 1996-12-18
SV1996000051A (es) 1997-02-17
NZ286791A (en) 1998-01-26
HUP9601635A3 (en) 2000-06-28
HU9601635D0 (en) 1996-08-28
EA199600029A3 (ru) 1997-03-31
CN1152434A (zh) 1997-06-25
US5958445A (en) 1999-09-28
IN182040B (xx) 1998-12-12
EA199600029A2 (ru) 1996-12-30
KR970000228A (ko) 1997-01-21
JPH093071A (ja) 1997-01-07
AU711853B2 (en) 1999-10-21
HUP9601635A2 (en) 1997-04-28
CO4700456A1 (es) 1998-12-29
AU5588096A (en) 1997-01-02
EA000047B1 (ru) 1998-04-30

Similar Documents

Publication Publication Date Title
IL118637A0 (en) Oral pharmaceutical compositions of S(+)-ibuprofen
IL118636A (en) Oral pharmaceutical compositions of S(+)-etodolac
AU7256296A (en) Use of metallofluorocomplexes for dental compositions
PL322136A1 (en) Oral compositions
IL117860A0 (en) Substituted 1-phenyl-3-pyrazolecarboxamides their preparation and pharmaceutical compositions containing them
IL122293A0 (en) Substituted 4-phenylaminothiazoles their preparation and pharmaceutical compositions containing them
ZA967827B (en) Pharmaceutical compositions
HUP0003757A3 (en) Oral pharmaceutical compositions of levosimendan
GB9513694D0 (en) Oral compositions
PL319898A1 (en) Cyclosporines containing compositions for oral administration
GB9515597D0 (en) Oral compositions
EG24294A (en) Pharmaceutical compositions
HU9500618D0 (en) Oral pharmaceutical compositions
IL114673A (en) Pharmaceutical compositions containing protein for oral administration
GB9506382D0 (en) Pharmaceutical compositions
ZA96525B (en) Novel pharmaceutical compositions
GB9513972D0 (en) Pharmaceutical compositions
ZA964517B (en) Oral pharmaceutical composition of piperidinoalkanol compounds in solution form
HUP9801282A3 (en) Oral compositions
HUP9801706A3 (en) Oral compositions
ZA974125B (en) Oral pharmaceutical compositions
IL114388A0 (en) Manufacture of pharmaceutical compositions comprising certain arylalkyl-amides
GB9513693D0 (en) Oral compositions
GB9510391D0 (en) Oral compositions
ZA976144B (en) Oral pharmaceutical compositions

Legal Events

Date Code Title Description
FF Patent granted
MM9K Patent not in force due to non-payment of renewal fees